文献速递妇科

局部晚期宫颈癌患者存在转移性腹主动脉旁淋巴结是否应采取更积极的治疗策略

Should the Presence of Metastatic Para-Aortic Lymph Nodes in Locally Advanced Cervical Cancer Lead to More Aggressive Treatment Strategies?
PubMed 文献 · J Minim Invasive Gynecol · 2017-02-01

西班牙单中心2009至2015年回顾性研究纳入139例局部晚期宫颈癌患者,术前接受腹腔镜腹主动脉旁淋巴结切除术。18.7%患者发现转移性腹主动脉旁淋巴结,其生存期显著短于无转移者(中位21个月 vs 均值76.9个月,p<.0001)。转移性淋巴结和肿瘤>5cm均为不良生存独立危险因素。

要点

  • 局部晚期宫颈癌术前腹腔镜腹主动脉旁淋巴结切除可发现18.7%的转移病例。
  • 转移性腹主动脉旁淋巴结患者中位生存期21个月,无转移者平均生存期76.9个月。
  • 转移性淋巴结(OR 117.5)和肿瘤>5cm(OR 21.5)为不良生存独立危险因素。

核心结论

  • 局部晚期宫颈癌伴转移性腹主动脉旁淋巴结患者预后差、生存率低,作者推测与隐藏的系统性疾病及治疗后高复发率有关,认为应努力改善该亚组患者的治疗策略。

研究设计与样本

  • 回顾性研究,纳入2009至2015年在西班牙加那利群岛Complejo Hospitalario Universitario Insular-Materno Infantil妇科肿瘤科接受术前腹腔镜腹主动脉旁淋巴结切除术的局部晚期宫颈癌患者,共139例。
  • 所有患者术后接受根治性放化疗,转移性腹主动脉旁淋巴结患者接受扩展的腰主动脉放疗。
  • 采用Kaplan-Meier法进行生存分析,统计学显著性设定为p<.05。

主要发现

  • 患者中位年龄48岁(范围28-73岁),最常见组织学类型为鳞状细胞癌(77%),最常见2009 FIGO分期为IIB期(48.2%)。
  • 腹腔镜腹主动脉旁淋巴结切除术发现转移性腹主动脉旁淋巴结者占18.7%(n=26)。
  • 随访23个月后,全人群平均总生存期为68.2个月(95%CI 63-73.4)。
  • 无腹主动脉旁转移患者平均生存时间为76.9个月(95%CI 70.3-80.4),而有转移性腹主动脉旁淋巴结患者中位生存时间为21个月(95%CI 6.1-35.9;p<.0001)。
  • 逻辑回归分析显示,转移性腹主动脉旁淋巴结(OR 117.5;95%CI 11.6-990.2;p<.0001)和肿瘤大小>5cm(OR 21.5;95%CI 2-230.3;p=.01)均为不良生存的独立危险因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To evaluate risk factors in patients with locally advanced cervical cancer (LACC) undergoing pretherapeutic laparoscopic para-aortic lymphadenectomy (LPL) as well as the progression-free and overall survival rates specifically in the subgroup of patients with metastatic para-aortic lymph nodes (PLNs). DESIGN: Retrospective study conducted on demographic data, pathologic and surgical findings, complications, and disease status recorded for LACC patients undergoing LPL during the period 2009 to 2015. SETTING: Department of Gynecologic Oncology of the Complejo Hospitalario Universitario Insular-Materno Infantil, Canary Islands, Spain (Canadian Task Force Classification II-3). PATIENTS: Women with LACC undergoing pretherapeutic LPL. All patients were treated with definitive chemoradiotherapy after surgery, and those with metastatic PLN received extended lumboaortic radiation therapy. INTERVENTIONS: Survival analysis was performed with the Kaplan-Meier method. Statistical significance was considered for p <.05. MEASUREMENTS AND MAIN RESULTS: The study included 139 patients. The median age was 48 years (range, 28-73). The most frequent histologic type was squamous cell carcinoma (77%), and the most frequent 2009 FIGO stage was IIB (48.2%). LPL identified metastatic PLN in 18.7% of patients (n = 26). The mean overall survival for the whole population, after 23 months of follow-up, was 68.2 months (95% CI, 63-73.4). For patients without para-aortic metastases, the mean survival time was 76.9 months (95% CI, 70.3-80.4), whereas for patients with positive PLNs the median survival time was 21 months (95% CI, 6.1-35.9; p <.0001). A logistic regression analysis revealed that the presence of metastatic PLNs and tumor size (>5 cm) were both independent risk factors for poor survival (OR, 117.5; 95% CI, 11.6-990.2; p <.0001, and OR, 21.5; 95% CI, 2-230.3; p = .01, respectively). CONCLUSION: LACC patients with metastatic PLNs had a poor prognosis and low survival rate. We postulate that this finding could be accounted for by the presence of hidden systemic disease and high recurrence rate after therapy. Efforts should be made to improve available therapeutic strategies for this particular subgroup of patients.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Benito V, Carballo S, Silva P, et al. Should the Presence of Metastatic Para-Aortic Lymph Nodes in Locally Advanced Cervical Cancer Lead to More Aggressive Treatment Strategies? J Minim Invasive Gynecol. 2017. PMID: 28161495. doi:10.1016/j.jmig.2017.01.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。